Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Cell Rep. 2013 Apr 25;3(4):1164-74. doi: 10.1016/j.celrep.2013.03.028. Epub 2013 Apr 18.
BubR1 insufficiency occurs with natural aging and induces progeroid phenotypes in both mice and children with mosaic variegated aneuploidy syndrome. In response to BubR1 insufficiency, skeletal muscle, fat, and lens tissue engage p19(Arf) to attenuate senescence and age-related deterioration. Here, we address how p19(Arf) exerts this caretaker role using BubR1 progeroid mice lacking p53 or its transcriptional target p21. We show that p53 delays functional decline of skeletal muscle and fat in a p21-dependent fashion by inhibiting p16(Ink4a)-mediated senescence of progenitor cells. Strikingly, p53 also attenuates the formation of cataractous lenses, but here its antiaging effect is p21 independent, as we found p21 to promote senescence of lens epithelial cells and cataract formation. Together, these results demonstrate that p53 counteracts tissue destruction in response to BubR1 insufficiency through diverse mechanisms and uncover a causal link between senescence of the progenitor cell compartment and age-related dysfunction.
BubR1 功能不全可随自然衰老而发生,并在小鼠和患有镶嵌性杂合性非整倍体综合征的儿童中诱导早熟表型。为了应对 BubR1 功能不全,骨骼肌、脂肪和晶状体组织利用 p19(Arf)来减轻衰老和与年龄相关的恶化。在这里,我们使用缺乏 p53 或其转录靶标 p21 的 BubR1 早熟小鼠来探讨 p19(Arf)如何发挥这种保护作用。我们表明,p53 通过抑制祖细胞中 p16(Ink4a)介导的衰老,以 p21 依赖的方式延迟骨骼肌和脂肪的功能下降。引人注目的是,p53 还可减轻白内障晶状体的形成,但此处其抗衰老作用与 p21 无关,因为我们发现 p21 可促进晶状体上皮细胞衰老和白内障形成。总之,这些结果表明,p53 通过多种机制来对抗 BubR1 功能不全引起的组织破坏,并揭示了祖细胞区室衰老与与年龄相关的功能障碍之间的因果关系。